Why Attend Europe's Premier Tumour Models Forum?
Join the only dedicated European event focused exclusively on preclinical and translational tumour modelling. Explore how leading organisations are improving model validation, integrating AI, implementing human-relevant platforms, predicting safety and efficacy, and improving confidence in oncology development decisions from discovery through to the clinic.
Unmissable Event Highlights
Human-Relevant Models & NAMs
Learn how AstraZeneca, Merck and Molecular Partners are implementing microphysiological systems, spheroids and alternative approaches to improve biological relevance and reduce reliance on traditional animal studies.
Translational Confidence & Model Predictiveness
Hear from Roche, Immunokey, Immuneering and Hemispherian on how organisations are identifying which models genuinely predict clinical outcomes.
AI & Computational Biology
Understand how AI, machine learning and computational modelling are being used to improve predictive modelling, translational insights and decision-making.
Tumour Microenvironment Innovation
Understand how AI, machine learning and computational modelling are being used to improve predictive modelling, translational insights and decision-making.
Safety, Efficacy & Therapeutic Index Prediction
Discover how AstraZeneca and Immunocore are incorporating biomarkers, quantitative modelling and human-relevant systems to improve prediction of toxicity and clinical outcomes.
Regulatory & Reverse Translation Strategies
Learn how organisations are refining future models using clinical learnings, reverse translation approaches and evolving regulatory requirements.
Explore the 2026 Event Guide
- Free* to attend for biotech & pharma
- Discover how Roche, AstraZeneca & J&J are improving translational confidence
- Explore how AI and computational modelling are transforming oncology decision-making
- Benchmark emerging human-relevant models, NAMs & tumour microenvironment platforms
- Learn practical strategies to improve model validation and predictive power
- Preview 20+ industry-led case studies, evidence presentations & insight exchanges
Attending Companies Include
Explore the Agenda
Discover how leading oncology teams are building more predictive, translationally relevant tumour models.
Partner With Us
Meet the scientists and decision-makers actively evaluating new model systems, biomarkers, NAMs and CRO partners.
Join Industry Experts
Benchmark strategies with biology, pharmacology, translational and safety leaders from across pharma and biotech.